130 related articles for article (PubMed ID: 30706385)
1. HDAC2-mediated upregulation of IL-6 triggers the migration of osteosarcoma cells.
Li J; Yan X; Tang J; Wang Y; Tang J; Wu W; Liu M
Cell Biol Toxicol; 2019 Oct; 35(5):423-433. PubMed ID: 30706385
[TBL] [Abstract][Full Text] [Related]
2. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.
Ashburner BP; Westerheide SD; Baldwin AS
Mol Cell Biol; 2001 Oct; 21(20):7065-77. PubMed ID: 11564889
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms underlying the inhibitory effects of bovine lactoferrin on osteosarcoma.
Chea C; Haing S; Miyauchi M; Shrestha M; Imanaka H; Takata T
Biochem Biophys Res Commun; 2019 Jan; 508(3):946-952. PubMed ID: 30545626
[TBL] [Abstract][Full Text] [Related]
4. HDAC2 promotes the migration and invasion of non-small cell lung cancer cells via upregulation of fibronectin.
Li L; Mei DT; Zeng Y
Biomed Pharmacother; 2016 Dec; 84():284-290. PubMed ID: 27665474
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of TNFAIP1 inhibits growth and induces apoptosis in osteosarcoma cells through inhibition of the nuclear factor-κB pathway.
Zhang CL; Wang C; Yan WJ; Gao R; Li YH; Zhou XH
Oncol Rep; 2014 Sep; 32(3):1149-55. PubMed ID: 24969828
[TBL] [Abstract][Full Text] [Related]
6. Visfatin triggers the in vitro migration of osteosarcoma cells via activation of NF-κB/IL-6 signals.
Wang GJ; Shen NJ; Cheng L; Yehan Fang ; Huang H; Li KH
Eur J Pharmacol; 2016 Nov; 791():322-330. PubMed ID: 27568842
[TBL] [Abstract][Full Text] [Related]
7. G-protein-coupled estrogen receptor suppresses the migration of osteosarcoma cells via post-translational regulation of Snail.
Wang Z; Chen X; Zhao Y; Jin Y; Zheng J
J Cancer Res Clin Oncol; 2019 Jan; 145(1):87-96. PubMed ID: 30341688
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression.
Zeng H; Zhang JM; Du Y; Wang J; Ren Y; Li M; Li H; Cai Z; Chu Q; Yang C
Oncotarget; 2016 Feb; 7(6):7329-42. PubMed ID: 26797758
[TBL] [Abstract][Full Text] [Related]
9. HDAC1 and HDAC2 regulate anti-inflammatory effects of anesthetic isoflurane in human monocytes.
Guo X; Deng J; Zheng B; Liu H; Zhang Y; Ying Y; Jia J; Ruan X
Immunol Cell Biol; 2020 Apr; 98(4):318-331. PubMed ID: 31950542
[TBL] [Abstract][Full Text] [Related]
10. Ezrin/NF-κB Pathway Regulates EGF-induced Epithelial-Mesenchymal Transition (EMT), Metastasis, and Progression of Osteosarcoma.
Liu P; Yang P; Zhang Z; Liu M; Hu S
Med Sci Monit; 2018 Apr; 24():2098-2108. PubMed ID: 29628496
[TBL] [Abstract][Full Text] [Related]
11. The CtBP1-HDAC1/2-IRF1 transcriptional complex represses the expression of the long noncoding RNA GAS5 in human osteosarcoma cells.
Zhang X; Du K; Lou Z; Ding K; Zhang F; Zhu J; Chang Z
Int J Biol Sci; 2019; 15(7):1460-1471. PubMed ID: 31337976
[TBL] [Abstract][Full Text] [Related]
12. Activation of GPER suppresses the malignancy of osteosarcoma cells via down regulation of IL-6 and IL-8.
Zha Z; Su A; Huo S
Arch Biochem Biophys; 2018 Dec; 660():149-155. PubMed ID: 30385323
[TBL] [Abstract][Full Text] [Related]
13. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
14. Sumoylation of HDAC2 promotes NF-κB-dependent gene expression.
Wagner T; Kiweler N; Wolff K; Knauer SK; Brandl A; Hemmerich P; Dannenberg JH; Heinzel T; Schneider G; Krämer OH
Oncotarget; 2015 Mar; 6(9):7123-35. PubMed ID: 25704882
[TBL] [Abstract][Full Text] [Related]
15. Decreased Histone Deacetylase 2 (HDAC2) in Peripheral Blood Monocytes (PBMCs) of COPD Patients.
Tan C; Xuan L; Cao S; Yu G; Hou Q; Wang H
PLoS One; 2016; 11(1):e0147380. PubMed ID: 26809128
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of FKBP3 suppresses nasopharyngeal carcinoma cell growth, invasion and migration, deactivated NF-κB/IL-6 signaling pathway through inhibiting histone deacetylase 2 expression.
Dong J; Chen J; Li Q; Qiu S
Chin J Physiol; 2023; 66(2):85-92. PubMed ID: 37082996
[TBL] [Abstract][Full Text] [Related]
17. Paeonol antagonizes oncogenesis of osteosarcoma by inhibiting the function of TLR4/MAPK/NF-κB pathway.
Zhou J; Liu Q; Qian R; Liu S; Hu W; Liu Z
Acta Histochem; 2020 Jan; 122(1):151455. PubMed ID: 31587886
[TBL] [Abstract][Full Text] [Related]
18. HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy.
La Noce M; Paino F; Mele L; Papaccio G; Regad T; Lombardi A; Papaccio F; Desiderio V; Tirino V
J Exp Clin Cancer Res; 2018 Dec; 37(1):296. PubMed ID: 30509303
[TBL] [Abstract][Full Text] [Related]
19. Activation of TNF-α/NF-κB axis enhances CRL4B
Zhang C; Chen B; Jiang K; Lao L; Shen H; Chen Z
Mol Oncol; 2018 Apr; 12(4):476-494. PubMed ID: 29377600
[TBL] [Abstract][Full Text] [Related]
20. The novel inhibitor BRM270 downregulates tumorigenesis by suppression of NF-κB signaling cascade in MDR-induced stem like cancer-initiating cells.
Mongre RK; Sodhi SS; Ghosh M; Kim JH; Kim N; Park YH; Kim SJ; Heo YJ; Sharma N; Jeong DK
Int J Oncol; 2015; 46(6):2573-85. PubMed ID: 25872586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
